Surgical treatment of non-tuberculous mycobacterial lung disease: Strike in time

International Journal of Tuberculosis and Lung Disease

Volumn 14, Issue 1, 2010, Pages 99-105

  Van Ingen, J ^a,b   Verhagen, A F T M ^a   Dekhuijzen, P N R ^a   Van Soolingen, D ^b   Magis Escurra, C ^a   Boeree, M J ^a   De Lange, W C M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Atypical mycobacteria; Lobectomy; Multidrug resistant tuberculosis; Non tuberculous mycobacteria; Surgery

Indexed keywords

ADULT; ARTICLE; CARDIOPULMONARY FUNCTION; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; LUNG DISEASE; LUNG INFECTION; LUNG RESECTION; MALE; MEDICAL LITERATURE; MYCOBACTERIUM; MYCOBACTERIUM AVIUM; PATIENT SELECTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT INDICATION;

ADULT; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; MYCOBACTERIUM; MYCOBACTERIUM AVIUM; MYCOBACTERIUM INFECTIONS; NETHERLANDS; PATIENT SELECTION; PNEUMONECTOMY; RECURRENCE; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 76149107173     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Griffith D E, Aksamit T, Brown-Elliot B A, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175: 367-416.
2. Lam P K, Griffith D E, Aksamit T R, et al. Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease. Am J Respir Crit Care Med 2006; 173: 1283-1289.
3. Research Committee of the British Thoracic Society. Clarithromycin vs. ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of the value of Mycobacterium vaccae immuno-therapy. Thorax 2008; 63: 627-634.
4. van Ingen J, Bendien S A, de Lange W C M, et al. The clinical relevance of nontuberculous mycobacteria isolated in the Nijmegen-Arnhem region, the Netherlands. Thorax 2009; 64: 502-506.
5. Pomerantz B J, Cleveland J C Jr, Olson H K, Pomerantz M. Pulmonary resection for multi-drug resistant tuberculosis. J Thorac Cardiovasc Surg 2001; 121: 448-453.
6. Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society. Management of opportunist mycobacterial infections: Joint Tuberculosis Committee guidelines 1999. Thorax 2000; 55: 210-218.
7. Mitchell J D, Bishop A, Cafaro A, Weyant M J, Pomerantz M. Anatomic lung resection for nontuberculous mycobacterial disease. Ann Thorac Surg 2008; 85: 1887-1893.
8. Wallace R J Jr, Glassroth J, Griffith D E, et al.; American Thoracic Society. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 1997; 156 (Suppl): S1-S25.
9. van Klingeren B, Dessens-Kroon M, van der Laan T, et al. Drug susceptibility testing of Mycobacterium tuberculosis complex using a high throughput, reproducible, absolute concentration method. J Clin Microbiol 2007; 45: 2662-2668.
10. British Thoracic Society and Society of Cardiothoracic Surgeons of Great Britain and Ireland Working Party. Guidelines on the selection of patients with lung cancer for surgery. Thorax 2001; 56: 89-108.
11. Colice G L, Shafazand S, Griffin J P, et al; American College of Chest Physicians. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest 2007; 132 (Suppl): S161-S177.
12. Corpe R F. Surgical management of pulmonary disease due to Mycobacterium avium-intracellulare. Rev Infect Dis 1981; 3: 1064-1067.
13. Moran J F, Alexander L G, Staub E W, et al. Long-term results of pulmonary resection for atypical mycobacterial disease. Ann Thorac Surg 1983; 35: 597-604.
14. Pomerantz M, Madsen L, Goble M, et al. Surgical management of resistant mycobacterial tuberculosis and other mycobacterial pulmonary infections. Ann Thorac Surg 1991; 52: 1108-1112.
15. Ono N, Satoh K, Yokomise H, et al. Surgical management of Mycobacterium avium complex disease. Thorac Cardiovasc Surg 1997; 45: 311-313.
16. Shiraishi Y, Fukushima K, Komatsu H, et al. Early pulmonary resection for localized Mycobacterium avium complex disease. Ann Thorac Surg 1998; 66: 183-186.
17. Nelson K G, Griffith D E, Brown B A, et al. Results of operation in Mycobacterium avium-intracellulare lung disease. Ann Thorac Surg 1998; 66: 325-330.
18. Lang-Lazdunski L, Offredo C, Le Pimpec-Barthes F, et al. Pulmonary resection for Mycobacterium xenopi pulmonary infection. Ann Thorac Surg 2001; 72: 1877-1882.
19. Shiraishi Y, Nakajima Y, Takasuna K, et al. Surgery for Myco bacterium avium complex lung disease in the clarithromycin era. Eur J Cardiothorac Surg 2002; 21: 314-318.
20. Shiraishi Y, Nakajima Y, Katsuragi N, et al. Pneumonectomy for nontuberculous mycobacterial infections. Ann Thorac Surg 2004; 78: 399-403.
21. Sherwood J T, Mitchell J D, Pomerantz M. Completion pneumonectomy for chronic mycobacterial disease. J Thorac Cardiovasc Surg 2005; 129: 1258-1265.
22. Watanabe M, Hasegawa N, Ishizaka A, et al. Early pulmonary resection for Mycobacterium avium complex lung disease treated with macrolides and quinolones. Ann Thorac Surg 2006; 81: 2026-2030.
23. Wallace R J Jr, Brown B A, Griffith D E, et al. Clarithromycin regimens for pulmonary Mycobacterium avium complex. The first 50 patients. Am J Respir Crit Care Med 1996; 153: 1766-1772.
24. Jutte P C, Rutgers S R, van Altena R, et al. Penetration of isoniazid, rifampicin and pyrazinamide in tuberculous pleural effusion and psoas abscess. Int J Tuberc Lung Dis 2004; 8: 1368-1372.